Stanford researchers have developed an AI-powered "virtual scientist" capable of designing drug and vaccine candidates, marking a leap forward in biomedical research.
Director of Product Management at Bioquell, Guy Turner, explains how RBDS uses Bioquell’s 35% hydrogen peroxide vapour solution to eliminate pathogens, thus providing a 6-log sporicidal kill and eliminating all traces of COVID-19.
Dr Phillip Whiteman, Lecturer in Public Policy at the University of Birmingham, reflects on how the public sector has responded to the initial challenges of the COVID-19 pandemic.
UN’s Under-Secretary-General for Humanitarian Affairs, Mark Lowcock, stresses the importance of anticipatory action when it comes to humanitarian affairs.
Dr Bill Mitchell OBE, Director of Policy at the British Computer Society (BCS), highlights how technology changes you, when both your life and work exist mainly through the internet.
Doctor Allon Barsam, consultant eye surgeon and founder of Ophthalmic Consultants of London, calls attention to the unexplored devastation behind the NHS virus frontlines.
Professor Martin Michaelis and Dr Mark Wass, University of Kent, School of Biosiences, say it is crucial to overcome COVID-19 and to prepare for the next pandemic.
Professor Behzad Samii, professor of operations and supply chain management at Vlerick Business School, discusses how to fairly circulate a COVID-19 vaccine.
In response to the COVID-19 health crisis, Rajant Corporation, has capitalised on its in-house manufacturing and provided essential protective free-of-charge face masks to aid the valiant efforts of healthcare workers.
In order to make transformation more effective and beneficial in the long term, user-centred design must come into play, says Sam Menter, Co-founder and Managing Director of Mace & Menter.
